Susi Roger E. 4

4 · IRADIMED CORP · Filed Jan 27, 2026

AI-generated summary of this filing

Updated Jan 27, 2026

IRADIMED (IRMD) 10% Owner Roger E. Susi Sells 5,000 Shares

What Happened

Roger E. Susi, a 10% owner of IRADIMED CORP (IRMD), sold a total of 5,000 shares in open‑market transactions on January 26, 2026. The sales were: 4,339 shares at a weighted average price of $100.54 (proceeds $436,243) and 661 shares at a weighted average price of $101.38 (proceeds $67,012), for combined proceeds of approximately $503,255.
The sales were executed pursuant to a Rule 10b5‑1 trading plan adopted by Mr. Susi on June 16, 2025.

Key Details

Transaction dates: January 26, 2026 (reported on Form 4 filed Jan 27, 2026).
Prices reported: $100.54 (weighted avg for the 4,339‑share block; individual trades ranged $100.05–$100.95) and $101.38 (weighted avg for the 661‑share block; trades ranged $101.14–$101.65). The filer offers to provide per‑trade details upon request.
Shares owned after transaction: Not specified in the provided filing excerpt.
Notable footnotes: Sales were made under a pre‑arranged 10b5‑1 plan (adopted June 16, 2025). The filer disclaims beneficial ownership except to the extent of pecuniary interest.
Filing timeliness: Report filed the day after the transactions (no late filing indicated).

Context

Sales under 10b5‑1 plans are pre‑scheduled trading programs and are commonly used for routine disposition of shares; they do not, by themselves, indicate a change in the insider’s view of the company.
As a 10% owner (rather than an executive transaction), these sales reflect disposition by a significant holder and are reported under Section 16 rules.

Form 4

Period: 2026-01-26

DirectorCEO, President, Chairman10% Owner

Transactions

Sale
Common Stock
[F1][F2]
2026-01-26$100.54/sh−4,339$436,243→ 2,263,161 total(indirect: By Trust)
Sale
Common Stock
[F1][F3]
2026-01-26$101.38/sh−661$67,012→ 2,262,500 total(indirect: By Trust)

Holdings

Footnotes (4)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.
[F2]This transaction was executed in multiple trades at prices ranging from $100.05 to $100.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]This transaction was executed in multiple trades at prices ranging from $101.14 to $101.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.

Signature

/s/ Roger E. Susi|2026-01-27

1 file